CICP11

Across TCGA pan-cancer cohorts, CICP11 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of CICP11’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where CICP11 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types CICP11 is over-expressed in tumor.

HNSC, COAD, and KIRC are the cancer types where CICP11 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CICP11 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	All	+0.022	.006	6	view →
COAD	Male	II,III,IV	+0.019	.027	2	view →
KIRC	All	All	+0.009	.046	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

CICP11–HNSC

Open the HNSC breakdown →